A blend product puts two or more peptide sequences in a single lyophilized vial, and that one structural fact changes what its documentation has to prove. A single-peptide Certificate of Analysis answers one identity question and one purity question; a blend’s documentation has to answer them for each component, and then account for how the components relate to one another in the preparation. This is a reference for reading that documentation before ordering — what a blend’s records should establish and where the questions differ from a single peptide. It is not a guide to choosing between compounds or to any use beyond in-vitro laboratory research.
What a name encodes, and what it doesn’t
A blend’s name is usually built from its components, and in many cases from their proportions: a listing named for a combination of two compounds is telling you, in the title itself, which two single peptides are in the vial and often their approximate ratio. The name is a specification of intent — the formulation the product is meant to be. What the name cannot tell you is whether the specific vial you receive matches that intent. That is the job of the lot-specific documentation, and it is precisely the gap a blend’s CoA has to close: a name states the recipe, a certificate reports what a named laboratory measured in a named lot.
Identity has to be confirmed per component
For a single peptide, an identity result confirms that the sample is the molecule the listing claims — typically a mass-spectrometry measurement matched against the target sequence’s expected mass. A blend does not have a single target mass; it has one per component. Strong blend documentation therefore confirms each sequence separately, so that a two-component blend carries identity evidence for both peptides rather than a single combined figure that could hide a missing or substituted component. When you read a blend’s records, the question is concrete: does the documentation name and confirm every component the product name advertises, or does it report the blend as an undifferentiated whole?
Purity in a mixture is a different measurement
Purity for a single peptide is a straightforward proportion — how much of the sample is the target compound versus process-related impurities, usually read from an HPLC run as a percentage. In a deliberate mixture, that same chromatogram shows more than one intended peak, so a raw “99%” figure means something different than it does on a single peptide and can be easy to misread. What matters for a blend is whether the documentation distinguishes the intended components from genuine impurities — that the additional peaks a blend’s chromatogram shows are the other declared peptides, not contamination. A purity number reported without that distinction tells you less about a blend than it would about a single compound.
Ratios and proportions
Where a blend’s name states a ratio, that proportion is part of the specification, and how well it is documented varies. Some preparations are characterized only qualitatively — the components are present and identified — while others report the relative amount of each. Reading a blend’s documentation includes noticing which of these it provides: confirmation that the declared components are present and identified is the baseline, and any quantitative account of their proportions is an additional, stronger claim. Neither is a use recommendation; both are simply questions of how completely the vial is described.
Lot matching matters more, not less
Everything a lot-specific certificate does for a single peptide it has to do for a blend across more moving parts. A single certificate that names the lot on the vial and reports identity and purity for each component is the record that ties the physical vial to the advertised formulation. Because a blend has more that can vary — a missing component, a shifted proportion, an impurity in any one sequence — the lot number on the vial matching the lot the certificate describes is the load-bearing check, exactly as it is for a single compound and for the same reason: a certificate only certifies the lot it was run on.
Reconstitution follows the vial, not the components
A blend is reconstituted as one vial: the diluent is added to the combined lyophilate, and the resulting concentration is expressed for the preparation as a whole, with each component present in the proportion the formulation defines. The arithmetic is the same as for a single peptide — diluent volume against the stated content of the vial — and the general reconstitution and cold-chain handling considerations that apply to any lyophilized peptide apply here too. As with every product in the catalog, a blend is supplied strictly for in-vitro laboratory research and is not offered with human-use, dosing, or therapeutic guidance.